Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Batel

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
The British Journal of Psychiatry : the Journal of Mental Science|September 22, 2025
Severe alcohol withdrawal symptoms and the risk of suicidal acts in patients treated for alcohol use disorderClément Vansteene, Caroline Dubertret, Henri-Jean Aubin, et al.
Brain Research Bulletin|February 6, 2002
Reappraisal of the serotonin 5-HT(1B) receptor gene in alcoholism: of mice and menPhilip Gorwood, Franck Aissi, Philippe Batel, et al.
International Journal of Psychiatry in Medicine|December 9, 2009
The role of brief motivational intervention on self-efficacy and abstinence in a cohort of patients with alcohol dependenceLucia Romo, Yann Le Strat, Caroline Aubry, et al.
Alcoholism, Clinical and Experimental Research|December 12, 2007
The 3' part of the dopamine transporter gene DAT1/SLC6A3 is associated with withdrawal seizures in patients with alcohol dependenceYann Le Strat, Nicolas Ramoz, Paul Pickering, et al.
Annales De Medecine Interne|September 10, 2002
Economic and social effects of high-dose buprenorphine substitution therapy. Six-month resultsPierre Lavignasse, William Lowenstein, Philippe Batel, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 8, 2021
Treating alcohol dependence with an abuse and misuse deterrent formulation of sodium oxybate: Results of a randomised, double-blind, placebo-controlled studyJulien Guiraud, Giovanni Addolorato, Henri-Jean Aubin, et al.
Addiction (Abingdon, England)|April 10, 2024
Prazosin and cyproheptadine in combination in the treatment of alcohol use disorder: A randomized, double-blind, placebo-controlled trialHenri-Jean Aubin, Ivan Berlin, Julien Guiraud, et al.
Drug and Alcohol Dependence|February 6, 2022
Occurrence and severity of cocaine-induced hallucinations: Two distinct phenotypes with shared clinical factors but specific genetic risk factorsEl-Hadi Zerdazi, Emmanuel Curis, Emily Karsinti, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|January 8, 2023
Sodium Oxybate for Alcohol Dependence: A Network Meta-Regression Analysis Considering Population Severity at Baseline and Treatment DurationJulien Guiraud, Giovanni Addolorato, Henri-Jean Aubin, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
The British Journal of Psychiatry : the Journal of Mental Science|September 22, 2025
Severe alcohol withdrawal symptoms and the risk of suicidal acts in patients treated for alcohol use disorderClément Vansteene, Caroline Dubertret, Henri-Jean Aubin, et al.
Brain Research Bulletin|February 6, 2002
Reappraisal of the serotonin 5-HT(1B) receptor gene in alcoholism: of mice and menPhilip Gorwood, Franck Aissi, Philippe Batel, et al.
International Journal of Psychiatry in Medicine|December 9, 2009
The role of brief motivational intervention on self-efficacy and abstinence in a cohort of patients with alcohol dependenceLucia Romo, Yann Le Strat, Caroline Aubry, et al.
Alcoholism, Clinical and Experimental Research|December 12, 2007
The 3' part of the dopamine transporter gene DAT1/SLC6A3 is associated with withdrawal seizures in patients with alcohol dependenceYann Le Strat, Nicolas Ramoz, Paul Pickering, et al.
Annales De Medecine Interne|September 10, 2002
Economic and social effects of high-dose buprenorphine substitution therapy. Six-month resultsPierre Lavignasse, William Lowenstein, Philippe Batel, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|July 8, 2021
Treating alcohol dependence with an abuse and misuse deterrent formulation of sodium oxybate: Results of a randomised, double-blind, placebo-controlled studyJulien Guiraud, Giovanni Addolorato, Henri-Jean Aubin, et al.
Addiction (Abingdon, England)|April 10, 2024
Prazosin and cyproheptadine in combination in the treatment of alcohol use disorder: A randomized, double-blind, placebo-controlled trialHenri-Jean Aubin, Ivan Berlin, Julien Guiraud, et al.
Drug and Alcohol Dependence|February 6, 2022
Occurrence and severity of cocaine-induced hallucinations: Two distinct phenotypes with shared clinical factors but specific genetic risk factorsEl-Hadi Zerdazi, Emmanuel Curis, Emily Karsinti, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|January 8, 2023
Sodium Oxybate for Alcohol Dependence: A Network Meta-Regression Analysis Considering Population Severity at Baseline and Treatment DurationJulien Guiraud, Giovanni Addolorato, Henri-Jean Aubin, et al.
Pageof 2